17-75239952-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138619.4(GGA3):c.1420G>A(p.Val474Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 1,579,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138619.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GGA3 | NM_138619.4 | c.1420G>A | p.Val474Ile | missense_variant | 13/17 | ENST00000537686.6 | NP_619525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GGA3 | ENST00000537686.6 | c.1420G>A | p.Val474Ile | missense_variant | 13/17 | 1 | NM_138619.4 | ENSP00000438085 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000897 AC: 17AN: 189618Hom.: 0 AF XY: 0.0000490 AC XY: 5AN XY: 102134
GnomAD4 exome AF: 0.0000273 AC: 39AN: 1427064Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 19AN XY: 707220
GnomAD4 genome AF: 0.000302 AC: 46AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.1420G>A (p.V474I) alteration is located in exon 13 (coding exon 13) of the GGA3 gene. This alteration results from a G to A substitution at nucleotide position 1420, causing the valine (V) at amino acid position 474 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at